{"id":"https://openalex.org/W4282944012","doi":"https://doi.org/10.1158/1538-7445.am2022-3552","title":"Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity","display_name":"Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282944012","doi":"https://doi.org/10.1158/1538-7445.am2022-3552"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-3552","doi":"https://doi.org/10.1158/1538-7445.am2022-3552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000107482","display_name":"Yuji Mishima","orcid":"https://orcid.org/0000-0002-5116-0835","observed_orcids":["https://orcid.org/0000-0002-5116-0835"]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Mishima","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001208577","display_name":"Fumiko Isoda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumiko Isoda","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013703823","display_name":"Noriko Matsumoto","orcid":"https://orcid.org/0000-0002-4054-9597","observed_orcids":["https://orcid.org/0000-0002-4054-9597"]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Matsumoto","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018473694","display_name":"Noriko Watanabe","orcid":"https://orcid.org/0000-0003-2193-3400","observed_orcids":["https://orcid.org/0000-0003-2193-3400"]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Watanabe","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018658292","display_name":"Kazushi Hiranuka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazushi Hiranuka","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013368069","display_name":"Takashi Yamada","orcid":"https://orcid.org/0000-0003-1797-3880","observed_orcids":["https://orcid.org/0000-0003-1797-3880"]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Yamada","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110665619","display_name":"Norihiro Fujinami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norihiro Fujinami","raw_affiliation_strings":["2National Cancer Center, Kashiwa, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Center, Kashiwa, Japan;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073355717","display_name":"Manami Shimomura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manami Shimomura","raw_affiliation_strings":["2National Cancer Center, Kashiwa, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Center, Kashiwa, Japan;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100691456","display_name":"Toshihiro Suzuki","orcid":"https://orcid.org/0000-0002-7095-6556","observed_orcids":["https://orcid.org/0000-0002-7095-6556"]},"institutions":[{"id":"https://openalex.org/I87531838","display_name":"Teikyo University","ror":"https://ror.org/01gaw2478","country_code":"JP","type":"education","lineage":["https://openalex.org/I87531838"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihiro Suzuki","raw_affiliation_strings":["3Teikyo University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Teikyo University, Tokyo, Japan","institution_ids":["https://openalex.org/I87531838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111889158","display_name":"Tetsuya Nakatsura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuya Nakatsura","raw_affiliation_strings":["2National Cancer Center, Kashiwa, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Center, Kashiwa, Japan;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107430281","display_name":"Norihiro Nakamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100136","display_name":"BrightPath Biotherapeutics (Japan)","ror":"https://ror.org/012ktab60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210100136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norihiro Nakamura","raw_affiliation_strings":["1BrightPath Biotherapeutics, Kawasaki, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BrightPath Biotherapeutics, Kawasaki, Japan;","institution_ids":["https://openalex.org/I4210100136"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"3552","last_page":"3552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoepitope-prediction","display_name":"neoepitope prediction","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7630000114440918},{"id":"https://openalex.org/keywords/dendritic-cell-maturation","display_name":"dendritic cell maturation","score":0.800000011920929},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6732307076454163},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.6399927139282227},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.6133697628974915},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5670714378356934},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.516899585723877},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5125441551208496},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4912566542625427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4829261004924774},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4762594699859619},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.46140968799591064},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.44748103618621826},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4253394901752472},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4228060245513916},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4169081449508667},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3822873830795288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09232640266418457}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-3552","doi":"https://doi.org/10.1158/1538-7445.am2022-3552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3204208825","https://openalex.org/W4409631472","https://openalex.org/W4386293495","https://openalex.org/W4417364455","https://openalex.org/W4409631730","https://openalex.org/W4401944544","https://openalex.org/W4417213077","https://openalex.org/W4408622859","https://openalex.org/W2396632584","https://openalex.org/W4412850097"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Personalized":[2,429],"neoantigen":[3,64,128,179,201,374,403,430],"cancer":[4,296,394,431,439],"vaccines":[5,202,395],"have":[6,50],"recently":[7],"showed":[8,150,208,376],"marked":[9],"therapeutic":[10,103,196],"potential":[11],"in":[12,24,105,115,120,130,191,195,289,344,349,355],"both":[13,131],"preclinical":[14],"and":[15,30,133,140,154,205,232,260,302,364],"early":[16],"phase":[17],"clinical":[18],"studies.":[19],"However,":[20],"significant":[21],"challenges":[22],"remain":[23],"the":[25,31,35,110,142,172,257,266,275,290,312,322,325,332,353,378,382,445],"accurate":[26],"prediction":[27],"of":[28,34,63,112,127,144,176,200,230,247,274,280,286,314,324,352,372,386,393,444],"neoepitopes":[29],"efficient":[32],"delivery":[33,241,335],"vaccine":[36,53,79,92,114,149,170,180,262,297,315,360,380,383,432],"components":[37],"for":[38,73,216,448],"eliciting":[39],"potent":[40],"antitumor":[41],"T":[42,212,233,346],"cell":[43,213],"responses.":[44],"To":[45],"overcome":[46],"these":[47],"challenges,":[48],"we":[49,123],"developed":[51,78],"novel":[52],"platform":[54,392],"designated":[55],"BP1209,":[56],"which":[57],"is":[58],"characterized":[59],"by":[60,99,236,244,253,256,265,321,331],"being":[61],"composed":[62],"peptides":[65,129,249,375],"that":[66,218,239,311,358,377],"contain":[67],"a":[68,86,95,125,167,223,370,397],"high":[69],"affinity":[70],"binding":[71],"motif":[72],"human":[74,134,206],"antibodies.":[75,90],"Methods:":[76],"We":[77,108,309],"with":[80,88,102,117,159,166,222],"enhanced":[81],"efficacy":[82,111,384],"designed":[83],"to":[84,181,336,400],"form":[85],"complex":[87,98],"checkpoint":[89,258],"The":[91],"instantly":[93],"assembles":[94],"divalent":[96],"peptide-antibody":[97],"simply":[100],"mixing":[101],"antibodies":[104,119,326],"physiological":[106],"condition.":[107],"evaluated":[109,141],"BP1209":[113,145,148,177,237,291,295,359,379],"combination":[116],"DC-targeting":[118],"vivo.":[121],"Next,":[122],"generated":[124],"series":[126],"murine":[132,178,204],"origins":[135],"using":[136,369],"in-house":[137],"bioinformatic":[138],"algorithms":[139],"advantages":[143],"vaccine.":[146,227],"Results:":[147],"robust":[151,187],"T-cell":[152,300,339],"response":[153,189,214,301,340],"anti-tumor":[155,188,303],"activity":[156,304],"when":[157],"combined":[158],"anti-CD40":[160],"agonistic":[161],"antibody":[162,173,259,267,437],"or":[163,171],"atezolizumab":[164],"compared":[165],"control":[168],"peptide":[169,226,240,263,269],"alone.":[174],"Treatment":[175],"syngeneic":[182],"tumor":[183,193,276],"bearing":[184],"mice":[185,282],"exhibited":[186],"resulting":[190],"complete":[192],"regression":[194],"setting.":[197],"Preclinical":[198],"evaluation":[199],"from":[203],"tumors":[207],"notably":[209],"increased":[210,245,261,333],"CD8+":[211,345],"even":[215],"epitopes":[217],"do":[219],"not":[220,319],"respond":[221],"conventional":[224,306],"long":[225],"Further":[228],"analysis":[229,273],"DCs":[231,251,328],"cells":[234],"induced":[235],"suggested":[238],"was":[242,317,341],"mediated":[243],"cross-presentation":[246,363],"epitope":[248,387],"on":[250,327,434],"supported":[252],"DC":[254,435],"maturation":[255],"uptake":[264],"mediating":[268],"delivery.":[270],"TCR":[271],"repertoire":[272],"infiltrating":[277],"lymphocytes":[278],"(TILs)":[279],"vaccinated":[281,292],"revealed":[283],"remarkable":[284,343],"accumulation":[285],"clonal":[287,350],"CTLs":[288],"group.":[293],"Conclusions:":[294],"dramatically":[298],"improves":[299,438],"over":[305],"long-peptide":[307],"vaccines.":[308,404],"demonstrated":[310],"enhancement":[313],"potency":[316],"achieved":[318],"only":[320],"function":[323],"but":[329],"mainly":[330],"antigen":[334,362],"DCs.":[337],"Enhanced":[338],"more":[342],"cells,":[347],"especially":[348],"expansion":[351],"CTL":[354],"TILs,":[356],"suggesting":[357],"facilitates":[361],"inducing":[365],"functional":[366],"CTLs.":[367],"Analysis":[368],"number":[371],"predicted":[373],"enhances":[381],"independent":[385],"sequences.":[388],"Thus,":[389],"our":[390],"new":[391],"provides":[396],"critical":[398],"solution":[399],"enhance":[401],"personalized":[402],"Citation":[405],"Format:":[406],"Yuji":[407],"Mishima,":[408],"Fumiko":[409],"Isoda,":[410],"Noriko":[411,413],"Matsumoto,":[412],"Watanabe,":[414],"Kazushi":[415],"Hiranuka,":[416],"Takashi":[417],"Yamada,":[418],"Norihiro":[419,427],"Fujinami,":[420],"Manami":[421],"Shimomura,":[422],"Toshihiro":[423],"Suzuki,":[424],"Tetsuya":[425],"Nakatsura,":[426],"Nakamura.":[428],"assembled":[433],"targeting":[436],"immunity":[440],"[abstract].":[441],"In:":[442],"Proceedings":[443],"American":[446],"Association":[447],"Cancer":[449,460],"Research":[450],"Annual":[451],"Meeting":[452],"2022;":[453],"2022":[454],"Apr":[455],"8-13.":[456],"Philadelphia":[457],"(PA):":[458],"AACR;":[459],"Res":[461],"2022;82(12_Suppl):Abstract":[462],"nr":[463],"3552.":[464]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-22T09:42:04.148104","created_date":"2022-06-16T00:00:00"}